PLCSF 8k- Merger AVAILABLE AS THEY WILL CONTAIN
Post# of 72711
Posted On: 08/22/2014 11:45:15 AM
PLCSF 8k- Merger
AVAILABLE AS THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED MERGER AND RELATED MATTERS.
http://archive.fast-edgar.com//20140822/AVZ3A...KZ6R7Z262/
52h = .10
Sitting at 52l,
go get em boys/girls
[ Outstanding Shares: 30,300,000
Float: 20,600,000
% Held by Insiders 30.1%
% Held by Institutions 2.80%
[10:43:32 AM] HDOGTX: At the meeting, shareholders of record as of August 11, 2014, will be asked to approve a series of proposals that would result in a wholly owned subsidiary of PLC merging with a private company, Viveve, Inc., and the RenalGuard operations of PLC being spun off into a private company owned by a current debt holder of PLC, GCP IV LLC. All proposals have been unanimously approved by PLC’s Board of Directors. A proxy statement containing more information about these proposals has been mailed to all stockholders of record as of the record date.
About PLC Systems Inc.
PLC Medical Systems, Inc., the operating subsidiary of PLC Systems Inc., is a medical device company focused on innovative technologies for the cardiac and vascular markets. PLC Medical Systems, Inc.'s lead product, RenalGuard®, significantly reduces the onset of CIN in at-risk patients undergoing certain cardiac and vascular imaging procedures. CIN is a form of acute kidney injury resulting from toxic contrast agents that occurs in 10% to 20% of at-risk patients. RenalGuard is CE-marked and is being sold in Europe and certain countries around the world via a network of distributors. Two investigator-sponsored studies in Europe have demonstrated RenalGuard's effectiveness at preventing CIN. The CIN-RG RenalGuard pivotal study is underway in the U.S. to support a planned Premarket Approval filing with the U.S. Food and Drug Administration. Additional company information can be found at www.plcmed.com.
AVAILABLE AS THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED MERGER AND RELATED MATTERS.
http://archive.fast-edgar.com//20140822/AVZ3A...KZ6R7Z262/
52h = .10
Sitting at 52l,
go get em boys/girls
[ Outstanding Shares: 30,300,000
Float: 20,600,000
% Held by Insiders 30.1%
% Held by Institutions 2.80%
[10:43:32 AM] HDOGTX: At the meeting, shareholders of record as of August 11, 2014, will be asked to approve a series of proposals that would result in a wholly owned subsidiary of PLC merging with a private company, Viveve, Inc., and the RenalGuard operations of PLC being spun off into a private company owned by a current debt holder of PLC, GCP IV LLC. All proposals have been unanimously approved by PLC’s Board of Directors. A proxy statement containing more information about these proposals has been mailed to all stockholders of record as of the record date.
About PLC Systems Inc.
PLC Medical Systems, Inc., the operating subsidiary of PLC Systems Inc., is a medical device company focused on innovative technologies for the cardiac and vascular markets. PLC Medical Systems, Inc.'s lead product, RenalGuard®, significantly reduces the onset of CIN in at-risk patients undergoing certain cardiac and vascular imaging procedures. CIN is a form of acute kidney injury resulting from toxic contrast agents that occurs in 10% to 20% of at-risk patients. RenalGuard is CE-marked and is being sold in Europe and certain countries around the world via a network of distributors. Two investigator-sponsored studies in Europe have demonstrated RenalGuard's effectiveness at preventing CIN. The CIN-RG RenalGuard pivotal study is underway in the U.S. to support a planned Premarket Approval filing with the U.S. Food and Drug Administration. Additional company information can be found at www.plcmed.com.
(0)
(0)Scroll down for more posts ▼